Kenvue Inc. logo

Kenvue Inc. (KVUE)

Market Closed
3 Jul, 20:00
NYSE NYSE
$
21. 05
+0.15
+0.72%
$
40.09B Market Cap
21.62 P/E Ratio
0.8% Div Yield
6,093,100 Volume
1.14 Eps
$ 20.9
Previous Close
Day Range
20.85 21.12
Year Range
17.67 25.17
Want to track KVUE and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Earnings results expected in 31 days
Looming Challenges, But Kenvue Could Become A Compelling Dividend Growth Stock Beyond 2025

Looming Challenges, But Kenvue Could Become A Compelling Dividend Growth Stock Beyond 2025

Kenvue, spun off from Johnson & Johnson, shows potential as a solid dividend stock post-2025 despite current economic challenges and recent earnings misses. The company boasts strong brands like Tylenol and Listerine, and management's cost-cutting initiatives aim to save $350 million by 2026. Kenvue's valuation and growth prospects make it attractive for long-term dividend investors, but cash flow headwinds warrant a hold rating for now.

Seekingalpha | 4 months ago
Buy 2 February S&P 500 Dividend Aristocrats Out Of 38 'Safer'

Buy 2 February S&P 500 Dividend Aristocrats Out Of 38 'Safer'

Five of the ten lowest-priced Dividend Aristocrats - Franklin Resources, Realty Income, Amcor, Hormel, and Kenvue - are recommended buys, offering dividends exceeding their single share prices. Analysts project net gains of 15.84% to 46.98% by February 2025 for the Top Ten Aristocrat Dogs, with an average gain of 21.63%. Ten Aristocrats show negative free cash flow margins, making them unsafe buys; Federal Realty, Kenvue, and PepsiCo are among them.

Seekingalpha | 4 months ago
Kenvue to Webcast Presentation at the Consumer Analyst Group of New York Conference

Kenvue to Webcast Presentation at the Consumer Analyst Group of New York Conference

SKILLMAN, N.J.--(BUSINESS WIRE)--Kenvue Inc. (NYSE: KVUE) today announced Thibaut Mongon, Chief Executive Officer, Paul Ruh, Chief Financial Officer, and Charmaine England, Chief Growth Officer, will present at the Consumer Analyst Group of New York (CAGNY) Conference on Wednesday, February 19, 2025, at 3:00 p.m. Eastern Time. A live webcast of the presentation will be available on investors.kenvue.com and a replay will be available on the website following the event. About Kenvue Kenvue Inc. i.

Businesswire | 4 months ago
Kenvue: An Intriguing Turnaround

Kenvue: An Intriguing Turnaround

Kenvue's stock has underperformed since its IPO, with disappointing guidance cuts for 2023 and 2024, and minimal growth projected for 2025. Despite recent struggles, Kenvue's strong brand portfolio, including Tylenol and Band-Aid, suggests potential for a turnaround, supported by activist investor Starboard Value. Execution issues, external factors, and potential structural changes have impacted Kenvue's performance, but improvements in marketing and management could drive future growth.

Seekingalpha | 4 months ago
Kenvue Is A Mediocre Candidate

Kenvue Is A Mediocre Candidate

Kenvue, the world's largest pure-play consumer health company, has a market cap of $37.96 billion but struggles with profitability despite decent growth. Management's cost-cutting initiatives show promise, but recent financials reveal mixed results, with revenue slightly up but net income and EBITDA declining. Kenvue's valuation appears relatively cheap compared to peers, yet its fundamentals don't justify a bullish outlook; thus, I rate it a 'hold'.

Seekingalpha | 4 months ago
Kenvue, Inc. (KVUE) Q4 2024 Earnings Call Transcript

Kenvue, Inc. (KVUE) Q4 2024 Earnings Call Transcript

Kenvue, Inc. (NYSE:KVUE ) Q4 2024 Earnings Conference Call February 6, 2025 8:00 AM ET Company Participants Thibaut Mongon - CEO Paul Ruh - CFO Sofya Tsinis - Head, IR Conference Call Participants Filippo Falorni - Citi Peter Grom - UBS Anna Lizzul - Bank of America Andrea Teixeira - J.P. Morgan Bonnie Herzog - Goldman Sachs Korinne Wolfmeyer - Piper Sandler Nik Modi - RBC Capital Markets Lauren Lieberman - Barclays Steve Powers - Deutsche Bank Operator Hello, and welcome to the Kenvue Fourth Quarter and Full-Year 2024 Earnings Conference Call.

Seekingalpha | 4 months ago
Kenvue (KVUE) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates

Kenvue (KVUE) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates

The headline numbers for Kenvue (KVUE) give insight into how the company performed in the quarter ended December 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

Zacks | 4 months ago
Kenvue's Q4 Sales Miss, Margins Improve

Kenvue's Q4 Sales Miss, Margins Improve

Consumer healthcare products specialist Kenvue (KVUE -0.34%) reported mixed fourth-quarter and full-year earnings on Thursday, Feb. 6. Adjusted earnings per share (EPS) of $0.26 aligned with the market's consensus expectations.

Fool | 4 months ago
Kenvue (KVUE) Q4 Earnings Meet Estimates

Kenvue (KVUE) Q4 Earnings Meet Estimates

Kenvue (KVUE) came out with quarterly earnings of $0.26 per share, in line with the Zacks Consensus Estimate. This compares to earnings of $0.31 per share a year ago.

Zacks | 4 months ago
Kenvue sees 2025 profit below estimates as strong dollar, weak cough product sales hit

Kenvue sees 2025 profit below estimates as strong dollar, weak cough product sales hit

Consumer health company Kenvue forecast 2025 adjusted profit below Wall Street estimates on Thursday, hit by a stronger dollar and weak demand for its cough and cold products that include Tylenol and Benadryl.

Reuters | 4 months ago
Kenvue Reports Full Year and Fourth Quarter 2024 Results

Kenvue Reports Full Year and Fourth Quarter 2024 Results

SKILLMAN, N.J.--(BUSINESS WIRE)--Kenvue Inc. (NYSE: KVUE), today announced financial results for the full year and fiscal fourth quarter ended December 29, 2024. “We delivered on our 2024 profit commitments despite headwinds that resulted in softer than expected sales growth and we enter 2025 as a more competitive company with stronger foundations,” said Thibaut Mongon, Chief Executive Officer. “We remain focused on leveraging our increased brand investments to accelerate growth and deliver lon.

Businesswire | 4 months ago
Kenvue Highlights Commitment to Shareholder Value

Kenvue Highlights Commitment to Shareholder Value

SKILLMAN, N.J.--(BUSINESS WIRE)--Kenvue confirms receipt of Starboard Value submission of nominees to stand for election to the Kenvue Board of Directors from.

Businesswire | 5 months ago
Loading...
Load More